# HCC Staging Modified by Tumor Micronecrosis

> **NCT05739110** · — · COMPLETED · sponsor: **Zhejiang University** · enrollment: 1100 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **BEHAVIORAL:** tumor micronecrosis

## Key facts

- **NCT ID:** NCT05739110
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-15
- **Primary completion:** 2022-12-01
- **Final completion:** 2023-01-15
- **Target enrollment:** 1100 (ACTUAL)
- **Last updated:** 2023-02-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05739110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05739110, "HCC Staging Modified by Tumor Micronecrosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05739110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*